Pharmaceuticals News

In a predefined MRI substudy, trevogrumab prevented 70% of muscle loss associated with semaglutide treatment  A pre-specified subgroup analysis found that patients meeting the low lean mass...

Phase 1b data: NovoBioJect increased active methotrexate in immune cells of rheumatoid arthritis patients by 38%. Phase 2a planned for 2027.

Press release – No. 19 / 2026 Zealand Pharma announces opening of new Research Hub in Cambridge, Massachusetts  Builds on the Metabolic Frontier 2030 strategy, advancing its ambition to become a...

PolyPid Submitted Marketing Authorization Application to European Medicines Agency for D-PLEX₁₀₀ Last month Validation confirms that the application is complete and EMA initiates formal review of...

SUNNYVALE, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...

Novonesis completes acquisition of MicroBioGen, strengthening its yeast capabilities The acquisition adds advanced yeast-breeding expertise with a proven track record in bioethanol and broader...

OCALA, Fla., Oct. 01, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today highlighted recent media coverage focused on the Company’s development strategy...

Application represents an important step in supporting reimbursement Company remains on track for U.S. commercial launch of LYTENAVA before year-end 2026 ISELIN, N.J., Oct. 01, 2026 (GLOBE...

SAN FRANCISCO and NEW YORK, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Manta Cares, an award-winning digital health company serving patients with cancer and their care partners, today announced a new...

BOSTON, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Vima Therapeutics, a clinical-stage biotechnology company focused on oral therapies for movement disorders, today announced that four poster presentations...